Biolife Solutions (BLFS) Research & Development (2010 - 2026)
Biolife Solutions (BLFS) posted quarterly Research & Development of $2.5 million for Q1 2026, up 75.54% year-over-year from $1.4 million in Q1 2025, and up 13.94% quarter-over-quarter from $2.2 million in Q4 2025.
Biolife Solutions (BLFS) Research & Development (2010 - 2026) Analysis & Trends
Biolife Solutions (BLFS) has reported Research & Development for 17 consecutive years, with $2.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Research & Development rose 75.54% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $10.0 million (up 35.52% YoY), while the FY2025 annual figure was $9.8 million, up 10.28% from the prior year.
- Research & Development advanced to $2.5 million in Q1 2026 per BLFS's latest filing, from $2.2 million in the prior quarter.
- Across five years, Research & Development topped out at $5.3 million in Q3 2022 and bottomed at -$7.2 million in Q4 2023.
- Historically, Research & Development has averaged $1.8 million across 5 years, with a median of $2.5 million in 2026.
- On a YoY basis, Research & Development climbed as much as 142.01% in 2022 and fell as far as 245.04% in 2022.
- Biolife Solutions' Research & Development stood at -$6.9 million in 2022, then fell by 4.13% to -$7.2 million in 2023, then surged by 121.7% to $1.6 million in 2024, then surged by 41.57% to $2.2 million in 2025, then gained by 13.94% to $2.5 million in 2026.
- Business Quant data shows BLFS's Research & Development at $2.5 million in Q1 2026, $2.2 million in Q4 2025, and $2.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 370.60 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 258.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 663.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 105.73 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 178.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 42.50 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 129.00 Mn |
| 10 | Biolife Solutions | 1.81 Bn | 1.72 Bn | 18.29 Mn | 2.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.96 Mn |
| Mar 31, 2026 | 2.53 Mn |
| Dec 31, 2025 | 2.22 Mn |
| Sep 30, 2025 | 2.53 Mn |
| Jun 30, 2025 | 2.73 Mn |
| Mar 31, 2025 | 1.44 Mn |
| Dec 31, 2024 | 1.57 Mn |
| Sep 30, 2024 | 1.89 Mn |
| Jun 30, 2024 | 2.48 Mn |
| Mar 31, 2024 | 2.08 Mn |
| Dec 31, 2023 | -7.22 Mn |
| Sep 30, 2023 | 3.74 Mn |
| Jun 30, 2023 | 3.83 Mn |
| Mar 31, 2023 | 4.15 Mn |
| Dec 31, 2022 | -6.93 Mn |
| Sep 30, 2022 | 5.28 Mn |
| Jun 30, 2022 | 3.43 Mn |
| Mar 31, 2022 | 4.89 Mn |
| Dec 31, 2021 | 4.78 Mn |
| Sep 30, 2021 | 4.07 Mn |